Gene: PLAC1
Official Full Name: placenta enriched 1provided by HGNC
Gene Summary: Involved in placenta development. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31559 | PLAC1 Knockout cell line (HeLa) | Human | PLAC1 | 1:3~1:6 | Negative | Online Inquiry |
KO31560 | PLAC1 Knockout cell line (HCT 116) | Human | PLAC1 | 1:2~1:4 | Negative | Online Inquiry |
KO31561 | PLAC1 Knockout cell line (HEK293) | Human | PLAC1 | 1:3~1:6 | Negative | Online Inquiry |
KO31562 | PLAC1 Knockout cell line (A549) | Human | PLAC1 | 1:3~1:4 | Negative | Online Inquiry |
PLAC1 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to study the functional implications of the placenta-specific 1 (PLAC1) gene. This product serves as a powerful research tool for understanding the roles of PLAC1 in a variety of biological processes, particularly those related to reproductive biology, tumorigenesis, and placental development.
These cell lines utilize CRISPR-Cas9 technology to create precise gene knockouts, thereby allowing researchers to investigate the loss-of-function effects of PLAC1. The eradication of PLAC1 expression aids in elucidating its involvement in key cellular pathways, including cell signaling, proliferation, differentiation, and apoptosis. Furthermore, this innovative approach enables scientists to analyze the phenotypic and molecular changes in the absence of PLAC1, providing insights that are crucial for advancing understanding in pathology and developmental biology.
Scientific importance is underscored by the potential implications of PLAC1 in both research and clinical settings. Investigating this gene may shed light on its contributions to trophoblastic diseases, such as choriocarcinoma, and facilitate the development of targeted therapies. Moreover, the PLAC1 Gene Knockout Cell Lines serve as important models for testing potential drug candidates and therapeutic strategies aimed at addressing conditions influenced by this gene.
What sets our product apart from alternatives is the comprehensive characterization of these cell lines, which have been validated for reproducibility and stability in culture. Additionally, our cell lines are available in various genetic backgrounds to suit specific research requirements. This versatility allows researchers to leverage the unique properties of PLAC1 in diverse biological contexts.
The PLAC1 Gene Knockout Cell Lines represent a significant advancement for researchers seeking to explore the functional mechanisms of gene expression in a controlled setting. By utilizing this innovative product, scientists can streamline their investigations and enhance the quality of their findings, driving forward both fundamental and applied science.
Our company prides itself on its commitment to excellence in genetic research products. With a robust portfolio of high-quality cell lines and a dedicated team of experts, we are positioned to support the advancement of biological research with cutting-edge solutions. Embrace the opportunity to elevate your research with our PLAC1 Gene Knockout Cell Lines and unlock new avenues of discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.